Key result
Metabolic compromise and older age were associated with significantly slower PCr on-kinetics compared with young and older trained volunteers (P<0.001), indicating greater mitochondrial inertia.
Why the study?
To investigate whether skeletal muscle phosphocreatine on-kinetics are slower in metabolically compromised and older individuals and whether they relate to carnitine acetyltransferase activity and physical function.
Cross-Sectional
p-value: p=<0.001
Skeletal muscle mitochondrial inertia, reflected by slower PCr on-kinetics, is greater in metabolically compromised and older individuals and correlates with reduced physical function, highlighting a potential therapeutic target.
Supports mitochondrial inertia in metabolic compromise and aging; hypothesis-generating, requiring prospective trials before clinical relevance.
BACKGROUNDAt the onset of exercise, the speed at which phosphocreatine (PCr) decreases toward a new steady state (PCr on-kinetics) reflects the readiness to activate mitochondrial ATP synthesis, which is secondary to Acetyl-CoA availability in skeletal muscle. We hypothesized that PCr on-kinetics are slower in metabolically compromised and older individuals and are associated with low carnitine acetyltransferase (CrAT) protein activity and compromised physical function.METHODSWe applied 31P-magnetic resonance spectroscopy (31P-MRS) to assess PCr on-kinetics in 2 cohorts of volunteers. Cohort 1 included patients who had type 2 diabetes, were obese, were lean trained (VO2max > 55 mL/kg/min), and were lean untrained (VO2max < 45 mL/kg/min). Cohort 2 included young (20-30 years) and older (65-80 years) individuals with normal physical activity and older, trained individuals. Previous results of CrAT protein activity and acetylcarnitine content in muscle tissue were used to explore the underlying mechanisms of PCr on-kinetics, along with various markers of physical function.RESULTSPCr on-kinetics were significantly slower in metabolically compromised and older individuals (indicating mitochondrial inertia) as compared with young and older trained volunteers, regardless of in vivo skeletal muscle oxidative capacity (P < 0.001). Mitochondrial inertia correlated with reduced CrAT protein activity, low acetylcarnitine content, and functional outcomes (P < 0.001).CONCLUSIONPCr on-kinetics are significantly slower in metabolically compromised and older individuals with normal physical activity compared with young and older trained individuals, regardless of in vivo skeletal muscle oxidative capacity, indicating greater mitochondrial inertia. Thus, PCr on-kinetics are a currently unexplored signature of skeletal muscle mitochondrial metabolism, tightly linked to functional outcomes. Skeletal muscle mitochondrial inertia might emerge as a target of intervention to improve physical function.TRIAL REGISTRATIONNCT01298375 and NCT03666013 (clinicaltrials.gov).FUNDINGRM and MH received an EFSD/Lilly grant from the European Foundation for the Study of Diabetes (EFSD). VS was supported by an ERC starting grant (grant 759161) "MRS in Diabetes."
No takes yet. Share an insight, caveat, or question.
Mancilla et al. (2022) conducted a cross-sectional in Metabolic compromise and aging. Metabolic compromise and older age vs. Young and older trained individuals was evaluated on PCr on-kinetics (p=<0.001). Metabolic compromise and older age were associated with significantly slower PCr on-kinetics compared with young and older trained volunteers (P<0.001), indicating greater mitochondrial inertia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: